The current role of calcineurin inhibitors in posttransplant immunosuppression?

Research output: Contribution to journalShort surveypeer-review

2 Scopus citations


It is important to determine when to use and when to avoid calcineurin inhibitors (CNIs). CNIs are associated with kidney dysfunction in some, but not all, transplant recipients. CNI-sparing protocols have their own drug-specific limitations. Two major clinical series suggest the benefit of routine CNI-sparing approaches, but our review suggests weaknesses in both. Ongoing studies are needed to determine which subgroups of recipients will benefit from CNIs.

Original languageEnglish (US)
Pages (from-to)2827-2829
Number of pages3
JournalAmerican Journal of Transplantation
Issue number12
StatePublished - Dec 2006


  • Calcineurin inhibitors
  • Immunosuppression
  • Kidney transplant
  • Nephrotoxicity


Dive into the research topics of 'The current role of calcineurin inhibitors in posttransplant immunosuppression?'. Together they form a unique fingerprint.

Cite this